Foundation for Interoperable Health Information Exchange Established
Written by IV Post
Monday, 22 December 2008
Washington, DC - The 5th Nationwide Health Information Network Forum, held this week in Washington, D.C., showcased the groundbreaking work of the Nationwide Health Information Network (NHIN) trial implementations which began more than 14 months ago.
Common Treatment for Chronic Prostatitis Fails to Reduce Symptoms
Written by IV Post
Monday, 22 December 2008
Washington, DC - Alfuzosin, a drug commonly prescribed for men with chronic prostatitis, a painful disorder of the prostate and surrounding pelvic area, failed to significantly reduce symptoms in recently diagnosed men who had not been previously treated with this drug, according to a clinical trial sponsored by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the National Institutes of Health (NIH).
Discovery Could Lead to Better Manufacturing Options for Cancer-fighting Antibodies
Written by Anne Trafton - MIT
Monday, 22 December 2008
Cambridge, Massachusetts - MIT engineers have found that antibodies do not need a particular sugar attachment long believed to be essential to their function, a discovery that could make producing therapeutic antibodies much easier and cheaper in the future.
Moderate Alcohol Consumption May Help Seniors Keep Disabilities at Bay
Written by Enrique Rivero - UCLA
Monday, 22 December 2008
Los Angeles, California - It is well known that moderate drinking can have positive health benefits - for instance, a couple of glasses of red wine a day can be good for the heart. But if you're a senior in good health, light to moderate consumption of alcohol may also help prevent the development of physical disability.
Cambridge, Massachusetts - Modifying the environment by using everything from shovels and plows to plant-derived pesticides may be as important as mosquito nets and vaccinations in the fight against malaria, according to a computerized analysis by MIT researchers.
Mouse Trap? Immunologist Calls for More Research on Humans, Not Mice
Written by Bruce Goldman
Sunday, 21 December 2008
Stanford, California - The fabled laboratory mouse, from which we have learned so much about how the immune system works can teach us only so much about how we humans get sick and what to do about it, says a leading researcher at the Stanford University School of Medicine.
FDA Approves Gleevec to Prevent Recurrence of Rare Gastrointestinal Cancer
Written by IV Post
Sunday, 21 December 2008
Washington, DC - The U.S. Food and Drug Administration today approved Gleevec (imatinib mesylate) for a new indication – keeping cancer from growing in patients following surgical removal of a gastrointestinal stromal tumor or GIST.
Cambridge, Massachusetts - Modifying the environment by using everything from shovels and plows to plant-derived pesticides may be as important as mosquito nets and vaccinations in the fight against malaria, according to a computerized analysis by MIT researchers.
